Italy · Delayed Price · Currency is EUR Philogen Statistics
Total Valuation
Philogen has a market cap or net worth of EUR 927.64 million. The enterprise value is 825.45 million.
| Market Cap | 927.64M |
| Enterprise Value | 825.45M |
Important Dates
The next estimated earnings date is Tuesday, September 23, 2025.
| Earnings Date | Sep 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Philogen has 40.33 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 28.96M |
| Shares Outstanding | 40.33M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.50% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 20.54 and the forward PE ratio is 2.55.
| PE Ratio | 20.54 |
| Forward PE | 2.55 |
| PS Ratio | 11.95 |
| PB Ratio | 6.69 |
| P/TBV Ratio | 6.75 |
| P/FCF Ratio | 23.99 |
| P/OCF Ratio | 22.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.85, with an EV/FCF ratio of 21.34.
| EV / Earnings | 18.23 |
| EV / Sales | 10.63 |
| EV / EBITDA | 19.85 |
| EV / EBIT | 21.90 |
| EV / FCF | 21.34 |
Financial Position
The company has a current ratio of 7.95, with a Debt / Equity ratio of 0.08.
| Current Ratio | 7.95 |
| Quick Ratio | 7.73 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.30 |
| Interest Coverage | 77.72 |
Financial Efficiency
Return on equity (ROE) is 39.51% and return on invested capital (ROIC) is 18.43%.
| Return on Equity (ROE) | 39.51% |
| Return on Assets (ROA) | 16.38% |
| Return on Invested Capital (ROIC) | 18.43% |
| Return on Capital Employed (ROCE) | 24.83% |
| Revenue Per Employee | 424,333 |
| Profits Per Employee | 247,497 |
| Employee Count | 183 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 7.11 |
Taxes
| Income Tax | -4.92M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.02% in the last 52 weeks. The beta is 0.15, so Philogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +8.02% |
| 50-Day Moving Average | 22.29 |
| 200-Day Moving Average | 20.76 |
| Relative Strength Index (RSI) | 51.13 |
| Average Volume (20 Days) | 14,776 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Philogen had revenue of EUR 77.65 million and earned 45.29 million in profits. Earnings per share was 1.12.
| Revenue | 77.65M |
| Gross Profit | 58.08M |
| Operating Income | 37.70M |
| Pretax Income | 40.38M |
| Net Income | 45.29M |
| EBITDA | 40.58M |
| EBIT | 37.70M |
| Earnings Per Share (EPS) | 1.12 |
Balance Sheet
The company has 113.73 million in cash and 11.54 million in debt, giving a net cash position of 102.18 million or 2.53 per share.
| Cash & Cash Equivalents | 113.73M |
| Total Debt | 11.54M |
| Net Cash | 102.18M |
| Net Cash Per Share | 2.53 |
| Equity (Book Value) | 138.66M |
| Book Value Per Share | 3.44 |
| Working Capital | 115.69M |
Cash Flow
In the last 12 months, operating cash flow was 40.84 million and capital expenditures -2.17 million, giving a free cash flow of 38.68 million.
| Operating Cash Flow | 40.84M |
| Capital Expenditures | -2.17M |
| Free Cash Flow | 38.68M |
| FCF Per Share | 0.96 |
Margins
Gross margin is 74.79%, with operating and profit margins of 48.54% and 58.33%.
| Gross Margin | 74.79% |
| Operating Margin | 48.54% |
| Pretax Margin | 52.00% |
| Profit Margin | 58.33% |
| EBITDA Margin | 52.25% |
| EBIT Margin | 48.54% |
| FCF Margin | 49.80% |
Dividends & Yields
Philogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.12% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.88% |
| FCF Yield | 4.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Philogen has an Altman Z-Score of 17.99 and a Piotroski F-Score of 6.
| Altman Z-Score | 17.99 |
| Piotroski F-Score | 6 |